X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (943) 943
penicillanic acid - therapeutic use (827) 827
penicillanic acid - analogs & derivatives (798) 798
piperacillin - therapeutic use (588) 588
male (570) 570
female (537) 537
anti-bacterial agents - therapeutic use (501) 501
middle aged (412) 412
index medicus (385) 385
adult (346) 346
aged (325) 325
pharmacology & pharmacy (259) 259
infectious diseases (224) 224
microbiology (224) 224
microbial sensitivity tests (217) 217
tazobactam (208) 208
penicillanic acid - administration & dosage (189) 189
penicillanic acid - pharmacology (172) 172
treatment outcome (169) 169
adolescent (165) 165
penicillanic acid - adverse effects (154) 154
piperacillin - administration & dosage (153) 153
bacterial infections - drug therapy (150) 150
antibiotics (146) 146
drug therapy, combination (143) 143
beta-lactamase inhibitors (137) 137
cephalosporins - therapeutic use (128) 128
anti-bacterial agents - administration & dosage (123) 123
piperacillin - adverse effects (122) 122
piperacillin - pharmacology (120) 120
drug therapy, combination - therapeutic use (119) 119
prospective studies (119) 119
piperacillin (114) 114
anti-bacterial agents - pharmacology (110) 110
infections (109) 109
aged, 80 and over (108) 108
animals (99) 99
child (92) 92
urinary tract infections - drug therapy (87) 87
ampicillin - therapeutic use (86) 86
anti-bacterial agents - adverse effects (86) 86
sulbactam (86) 86
piperacillin-tazobactam (85) 85
retrospective studies (84) 84
drug combinations (83) 83
penicillanic acid - pharmacokinetics (82) 82
piperacillin - pharmacokinetics (76) 76
pseudomonas aeruginosa - drug effects (75) 75
pseudomonas infections - drug therapy (73) 73
polycyclic compounds (72) 72
penicillins - therapeutic use (71) 71
piperacillin/tazobactam (70) 70
escherichia coli - drug effects (66) 66
pharmacokinetics (66) 66
therapy (64) 64
medicine, general & internal (62) 62
clinical trials as topic (61) 61
risk factors (61) 61
child, preschool (60) 60
bacteremia - drug therapy (59) 59
bacteria (59) 59
piperacillin, tazobactam drug combination (58) 58
amdinocillin pivoxil - therapeutic use (57) 57
anti-bacterial agents - pharmacokinetics (57) 57
cross infection - drug therapy (57) 57
escherichia coli infections - drug therapy (56) 56
health aspects (56) 56
drug resistance, bacterial (54) 54
infant (54) 54
thienamycins - therapeutic use (54) 54
double-blind method (53) 53
enzyme inhibitors - therapeutic use (53) 53
escherichia-coli (52) 52
immunology (52) 52
mortality (52) 52
bacterial infections - microbiology (51) 51
pneumonia (51) 51
research (51) 51
biochemical phenomena, metabolism, and nutrition (50) 50
oncology (50) 50
pediatrics (50) 50
time factors (50) 50
resistance (49) 49
bacteria - drug effects (48) 48
fever (48) 48
infusions, intravenous (48) 48
surgery (48) 48
bacteremia (46) 46
drug resistance, multiple, bacterial (46) 46
hospitals (46) 46
infection (46) 46
mice (46) 46
research article (46) 46
sepsis - drug therapy (46) 46
young adult (46) 46
dosage and administration (45) 45
drug therapy, combination - adverse effects (45) 45
enterobacteriaceae (45) 45
imipenem - therapeutic use (45) 45
bacterial infections and mycoses (44) 44
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (917) 917
Japanese (27) 27
German (19) 19
Spanish (18) 18
French (13) 13
Russian (8) 8
Chinese (6) 6
Polish (6) 6
Italian (4) 4
Norwegian (3) 3
Danish (2) 2
Hebrew (2) 2
Swedish (2) 2
Turkish (2) 2
Dutch (1) 1
Hungarian (1) 1
Serbian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Critical Care, ISSN 1364-8535, 07/2010, Volume 14, Issue 4, pp. R126 - R126
Journal Article
Science Translational Medicine, ISSN 1946-6234, 05/2016, Volume 8, Issue 339, pp. 339ra71 - 339ra71
Journal Article
Clinical Infectious Diseases, ISSN 1058-4838, 2012, Volume 54, Issue 2, pp. 167 - 174
Journal Article
Clinical Infectious Diseases, ISSN 1058-4838, 05/2015, Volume 60, Issue 9, pp. 1319 - 1325
Background. The effectiveness of piperacillin-tazobactam (PTZ) for the treatment of extended-spectrum beta-lactamase (ESBL) bacteremia is controversial. We... 
Resistance | ESBL | Carbapenem | Piperacillin-tazobactam | Gram-negative | MORTALITY | INFECTIOUS DISEASES | HOSPITALIZED-PATIENTS | RISK-FACTORS | gram-negative | KLEBSIELLA-PNEUMONIAE BACTEREMIA | ANTIMICROBIAL THERAPY | ESCHERICHIA-COLI | MICROBIOLOGY | IMMUNOLOGY | INHIBITOR COMBINATIONS | resistance | carbapenem | INTENSIVE-CARE-UNIT | piperacillin-tazobactam | BLOOD-STREAM INFECTIONS | ENTEROBACTERIACEAE | Klebsiella pneumoniae - isolation & purification | Klebsiella pneumoniae - drug effects | Escherichia coli - drug effects | Humans | Middle Aged | Bacteremia - mortality | Male | Bacteremia - microbiology | Microbial Sensitivity Tests | Anti-Bacterial Agents - therapeutic use | Time Factors | Penicillanic Acid - therapeutic use | Female | beta-Lactamases - metabolism | Penicillanic Acid - analogs & derivatives | Klebsiella oxytoca - drug effects | Enterobacteriaceae Infections - microbiology | Bacteremia - drug therapy | Enterobacteriaceae Infections - mortality | Proportional Hazards Models | Survival Rate | Klebsiella oxytoca - isolation & purification | Proteus mirabilis - isolation & purification | Propensity Score | Carbapenems - therapeutic use | Escherichia coli - isolation & purification | beta-Lactamase Inhibitors - therapeutic use | Aged | Proteus mirabilis - drug effects | Cohort Studies | Enterobacteriaceae Infections - drug therapy | Piperacillin - therapeutic use | Care and treatment | Dosage and administration | Tazobactam | Carbapenems | Piperacillin | Bacteremia | and Commentaries
Journal Article
Antimicrobial Agents and Chemotherapy, ISSN 0066-4804, 02/2013, Volume 57, Issue 2, pp. 708 - 715
Journal Article
Clinical Infectious Diseases, ISSN 1058-4838, 04/2017, Volume 64, Issue 7, pp. 972 - 980
Journal Article
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, ISSN 0098-7484, 09/2018, Volume 320, Issue 10, pp. 984 - 994
IMPORTANCE Extended-spectrum beta-lactamases mediate resistance to third-generation cephalosporins (eg, ceftriaxone) in Escherichia coli and Klebsiella... 
UNITED-STATES | MEDICINE, GENERAL & INTERNAL | EXTENDED-SPECTRUM | CEFEPIME | THERAPY | BACTEREMIA | LACTAMASE-PRODUCING ENTEROBACTERIACEAE | SPECTRUM BETA-LACTAMASES | EXTENSION | Escherichia coli Infections - mortality | Klebsiella pneumoniae - drug effects | Escherichia coli - drug effects | Humans | Middle Aged | Drug Resistance, Bacterial | Bacteremia - mortality | Ceftriaxone - pharmacology | Male | Cause of Death | Anti-Bacterial Agents - therapeutic use | Penicillanic Acid - therapeutic use | Adult | Female | Anti-Bacterial Agents - adverse effects | Meropenem | Penicillanic Acid - adverse effects | Thienamycins - adverse effects | Penicillanic Acid - analogs & derivatives | Thienamycins - therapeutic use | Escherichia coli Infections - drug therapy | Klebsiella Infections - drug therapy | Piperacillin, Tazobactam Drug Combination | Bacteremia - drug therapy | Piperacillin - adverse effects | Klebsiella Infections - mortality | Aged | Anti-Bacterial Agents - pharmacology | Piperacillin - therapeutic use | Klebsiella | Treatment outcome | Safety and security measures | Tazobactam | Escherichia coli | Patient outcomes | Analysis | Comparative analysis | Risk factors | Bacterial infections | Intravenous administration | Mortality | Clinical trials | Piperacillin-tazobactam | Infections | Ceftriaxone | Drug resistance | Patients | Side effects | Randomization | Cephalosporins | E coli | Piperacillin | Drug therapy | Blood diseases | Blood culture | Carbapenems | Original Investigation | Research
Journal Article
Drugs, ISSN 0012-6667, 1/2014, Volume 74, Issue 1, pp. 31 - 51
Journal Article
Critical Care, ISSN 1364-8535, 06/2011, Volume 15, Issue 3, pp. R137 - R137
Journal Article
Antimicrobial Agents and Chemotherapy, ISSN 0066-4804, 05/2010, Volume 54, Issue 5, pp. 1742 - 1748
Journal Article